

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | pyrimidine nucleobase catabolic process (GO:0006208) | 5.66586150 |
| 2 | regulation of posttranscriptional gene silencing (GO:0060147) | 5.53709588 |
| 3 | regulation of gene silencing by miRNA (GO:0060964) | 5.53709588 |
| 4 | regulation of gene silencing by RNA (GO:0060966) | 5.53709588 |
| 5 | establishment of integrated proviral latency (GO:0075713) | 5.30969051 |
| 6 | alpha-linolenic acid metabolic process (GO:0036109) | 5.08127897 |
| 7 | nucleobase catabolic process (GO:0046113) | 5.06933531 |
| 8 | pre-miRNA processing (GO:0031054) | 4.78126931 |
| 9 | nuclear pore complex assembly (GO:0051292) | 4.75326337 |
| 10 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.72788494 |
| 11 | sulfur amino acid catabolic process (GO:0000098) | 4.44857633 |
| 12 | nuclear pore organization (GO:0006999) | 4.39055594 |
| 13 | negative regulation of fibrinolysis (GO:0051918) | 4.37608888 |
| 14 | urea cycle (GO:0000050) | 4.27056059 |
| 15 | urea metabolic process (GO:0019627) | 4.27056059 |
| 16 | glycine metabolic process (GO:0006544) | 4.16979834 |
| 17 | L-phenylalanine metabolic process (GO:0006558) | 4.15041442 |
| 18 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.15041442 |
| 19 | lysine catabolic process (GO:0006554) | 4.14912151 |
| 20 | lysine metabolic process (GO:0006553) | 4.14912151 |
| 21 | cellular ketone body metabolic process (GO:0046950) | 4.14670028 |
| 22 | DNA unwinding involved in DNA replication (GO:0006268) | 4.10483185 |
| 23 | paraxial mesoderm development (GO:0048339) | 4.08110991 |
| 24 | cysteine metabolic process (GO:0006534) | 4.05958720 |
| 25 | low-density lipoprotein particle clearance (GO:0034383) | 4.05300658 |
| 26 | glyoxylate metabolic process (GO:0046487) | 4.04952342 |
| 27 | folic acid-containing compound biosynthetic process (GO:0009396) | 4.02926564 |
| 28 | chromatin remodeling at centromere (GO:0031055) | 4.01615674 |
| 29 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.98764332 |
| 30 | L-phenylalanine catabolic process (GO:0006559) | 3.98764332 |
| 31 | heterochromatin organization (GO:0070828) | 3.94540167 |
| 32 | serine family amino acid catabolic process (GO:0009071) | 3.93280580 |
| 33 | homocysteine metabolic process (GO:0050667) | 3.89693649 |
| 34 | protein complex localization (GO:0031503) | 3.88399393 |
| 35 | CENP-A containing nucleosome assembly (GO:0034080) | 3.87305980 |
| 36 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.80980522 |
| 37 | IMP biosynthetic process (GO:0006188) | 3.80079858 |
| 38 | nitrogen cycle metabolic process (GO:0071941) | 3.79712983 |
| 39 | establishment of viral latency (GO:0019043) | 3.79157863 |
| 40 | plasma lipoprotein particle clearance (GO:0034381) | 3.74826505 |
| 41 | ethanol oxidation (GO:0006069) | 3.74195239 |
| 42 | regulation of fibrinolysis (GO:0051917) | 3.73865483 |
| 43 | serine family amino acid biosynthetic process (GO:0009070) | 3.73007529 |
| 44 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.70733208 |
| 45 | protein carboxylation (GO:0018214) | 3.70733208 |
| 46 | aromatic amino acid family catabolic process (GO:0009074) | 3.68113243 |
| 47 | kynurenine metabolic process (GO:0070189) | 3.63802555 |
| 48 | IMP metabolic process (GO:0046040) | 3.62452181 |
| 49 | serine family amino acid metabolic process (GO:0009069) | 3.61556115 |
| 50 | protein localization to chromosome, centromeric region (GO:0071459) | 3.61496309 |
| 51 | regulation of protein activation cascade (GO:2000257) | 3.59487511 |
| 52 | pore complex assembly (GO:0046931) | 3.58509108 |
| 53 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.58299856 |
| 54 | amino-acid betaine metabolic process (GO:0006577) | 3.58112106 |
| 55 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.57039910 |
| 56 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.56369756 |
| 57 | complement activation, alternative pathway (GO:0006957) | 3.54338986 |
| 58 | regulation of triglyceride catabolic process (GO:0010896) | 3.54147604 |
| 59 | ketone body metabolic process (GO:1902224) | 3.53961931 |
| 60 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.53852915 |
| 61 | tetrahydrofolate metabolic process (GO:0046653) | 3.49349381 |
| 62 | histone arginine methylation (GO:0034969) | 3.49249896 |
| 63 | acetyl-CoA metabolic process (GO:0006084) | 3.46506116 |
| 64 | one-carbon metabolic process (GO:0006730) | 3.46412272 |
| 65 | tryptophan catabolic process (GO:0006569) | 3.45895033 |
| 66 | indole-containing compound catabolic process (GO:0042436) | 3.45895033 |
| 67 | indolalkylamine catabolic process (GO:0046218) | 3.45895033 |
| 68 | high-density lipoprotein particle remodeling (GO:0034375) | 3.45772333 |
| 69 | bile acid biosynthetic process (GO:0006699) | 3.44550828 |
| 70 | regulation of helicase activity (GO:0051095) | 3.44261591 |
| 71 | DNA strand elongation (GO:0022616) | 3.42641078 |
| 72 | epoxygenase P450 pathway (GO:0019373) | 3.41772059 |
| 73 | positive regulation of lipid catabolic process (GO:0050996) | 3.41292211 |
| 74 | tryptophan metabolic process (GO:0006568) | 3.41011251 |
| 75 | protein-lipid complex remodeling (GO:0034368) | 3.40652566 |
| 76 | macromolecular complex remodeling (GO:0034367) | 3.40652566 |
| 77 | plasma lipoprotein particle remodeling (GO:0034369) | 3.40652566 |
| 78 | reverse cholesterol transport (GO:0043691) | 3.39759692 |
| 79 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 3.39496475 |
| 80 | cellular modified amino acid catabolic process (GO:0042219) | 3.38988520 |
| 81 | regulation of complement activation (GO:0030449) | 3.37705472 |
| 82 | phospholipid homeostasis (GO:0055091) | 3.37048710 |
| 83 | histone exchange (GO:0043486) | 3.36528509 |
| 84 | mitotic metaphase plate congression (GO:0007080) | 3.36144014 |
| 85 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.35734697 |
| 86 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.35455806 |
| 87 | DNA replication-independent nucleosome organization (GO:0034724) | 3.35455806 |
| 88 | regulation of histone H3-K9 methylation (GO:0051570) | 3.32042364 |
| 89 | regulation of centriole replication (GO:0046599) | 3.30151969 |
| 90 | purine nucleobase biosynthetic process (GO:0009113) | 3.28192751 |
| 91 | DNA replication checkpoint (GO:0000076) | 3.27515455 |
| 92 | folic acid metabolic process (GO:0046655) | 3.27219642 |
| 93 | ribosome assembly (GO:0042255) | 3.27157981 |
| 94 | positive regulation of fatty acid oxidation (GO:0046321) | 3.26309506 |
| 95 | nucleobase biosynthetic process (GO:0046112) | 3.25879268 |
| 96 | mitotic sister chromatid cohesion (GO:0007064) | 3.25495274 |
| 97 | alpha-amino acid catabolic process (GO:1901606) | 3.24543085 |
| 98 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 3.23704913 |
| 99 | non-recombinational repair (GO:0000726) | 3.23088469 |
| 100 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.23088469 |
| 101 | regulation of cell fate specification (GO:0042659) | 3.21904477 |
| 102 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 3.21073570 |
| 103 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 3.21073570 |
| 104 | ATP-dependent chromatin remodeling (GO:0043044) | 3.20092931 |
| 105 | L-serine metabolic process (GO:0006563) | 3.19184398 |
| 106 | protein localization to kinetochore (GO:0034501) | 3.18391792 |
| 107 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.17509959 |
| 108 | bile acid metabolic process (GO:0008206) | 3.13339457 |
| 109 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.12581209 |
| 110 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.12581209 |
| 111 | regulation of cholesterol storage (GO:0010885) | 3.12057632 |
| 112 | negative regulation of cholesterol transport (GO:0032375) | 3.11422696 |
| 113 | negative regulation of sterol transport (GO:0032372) | 3.11422696 |
| 114 | primary alcohol catabolic process (GO:0034310) | 3.10809919 |
| 115 | cellular amino acid catabolic process (GO:0009063) | 3.09584140 |
| 116 | negative regulation of chromosome segregation (GO:0051985) | 3.06104322 |
| 117 | imidazole-containing compound metabolic process (GO:0052803) | 3.05960318 |
| 118 | negative regulation of sister chromatid segregation (GO:0033046) | 3.05607724 |
| 119 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 3.05607724 |
| 120 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 3.05607724 |
| 121 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 3.05607724 |
| 122 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 3.05607724 |
| 123 | cellular protein complex localization (GO:0034629) | 3.02844153 |
| 124 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 3.02470921 |
| 125 | regulation of mitotic spindle checkpoint (GO:1903504) | 3.02470921 |
| 126 | coenzyme catabolic process (GO:0009109) | 3.01233333 |
| 127 | acylglycerol homeostasis (GO:0055090) | 2.99105696 |
| 128 | triglyceride homeostasis (GO:0070328) | 2.99105696 |
| 129 | folic acid-containing compound metabolic process (GO:0006760) | 2.98678352 |
| 130 | DNA replication initiation (GO:0006270) | 2.97546094 |
| 131 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.97469238 |
| 132 | glutamate metabolic process (GO:0006536) | 2.96612954 |
| 133 | positive regulation of chromosome segregation (GO:0051984) | 2.96070104 |
| 134 | aldehyde catabolic process (GO:0046185) | 2.95517438 |
| 135 | low-density lipoprotein particle remodeling (GO:0034374) | 2.95092801 |
| 136 | metaphase plate congression (GO:0051310) | 2.94294338 |
| 137 | regulation of gene silencing (GO:0060968) | 2.92474523 |
| 138 | carnitine metabolic process (GO:0009437) | 2.92226994 |
| 139 | linoleic acid metabolic process (GO:0043651) | 2.91942019 |
| 140 | regulation of chromosome segregation (GO:0051983) | 2.91701558 |
| 141 | plasma lipoprotein particle assembly (GO:0034377) | 2.90919915 |
| 142 | 2-oxoglutarate metabolic process (GO:0006103) | 2.90430993 |
| 143 | bile acid and bile salt transport (GO:0015721) | 2.90302528 |
| 144 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.87400772 |
| 145 | negative regulation of DNA recombination (GO:0045910) | 2.86513122 |
| 146 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.86491326 |
| 147 | fibrinolysis (GO:0042730) | 2.85603266 |
| 148 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.85366331 |
| 149 | chaperone-mediated protein complex assembly (GO:0051131) | 2.84229683 |
| 150 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 2.83457318 |
| 151 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 2.83457318 |
| 152 | spindle checkpoint (GO:0031577) | 2.82224171 |
| 153 | maturation of 5.8S rRNA (GO:0000460) | 2.81430631 |
| 154 | mitotic spindle checkpoint (GO:0071174) | 2.81259158 |
| 155 | alanine transport (GO:0032328) | 2.80059337 |
| 156 | regulation of sister chromatid segregation (GO:0033045) | 2.79954818 |
| 157 | regulation of mitotic sister chromatid separation (GO:0010965) | 2.79954818 |
| 158 | regulation of mitotic sister chromatid segregation (GO:0033047) | 2.79954818 |
| 159 | DNA duplex unwinding (GO:0032508) | 2.77825516 |
| 160 | DNA damage response, detection of DNA damage (GO:0042769) | 2.77446004 |
| 161 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.77432724 |
| 162 | aromatic amino acid family metabolic process (GO:0009072) | 2.77159769 |
| 163 | midgut development (GO:0007494) | 2.76758538 |
| 164 | tyrosine metabolic process (GO:0006570) | 2.76554496 |
| 165 | mitotic sister chromatid segregation (GO:0000070) | 2.76258814 |
| 166 | negative regulation of fatty acid metabolic process (GO:0045922) | 2.76161809 |
| 167 | arginine metabolic process (GO:0006525) | 2.75939377 |
| 168 | cytolysis (GO:0019835) | 2.75729340 |
| 169 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.75245059 |
| 170 | regulation of translational fidelity (GO:0006450) | 2.75147864 |
| 171 | sister chromatid segregation (GO:0000819) | 2.75074094 |
| 172 | DNA geometric change (GO:0032392) | 2.74422692 |
| 173 | cellular glucuronidation (GO:0052695) | 2.74218751 |
| 174 | chromatin assembly or disassembly (GO:0006333) | 2.74143428 |
| 175 | regulation of centrosome cycle (GO:0046605) | 2.73857734 |
| 176 | regulation of sequestering of triglyceride (GO:0010889) | 2.73629545 |
| 177 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.73494138 |
| 178 | mitotic spindle assembly checkpoint (GO:0007094) | 2.69486018 |
| 179 | tRNA aminoacylation for protein translation (GO:0006418) | 2.69376938 |
| 180 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.68642531 |
| 181 | DNA strand renaturation (GO:0000733) | 2.68508645 |
| 182 | mitotic nuclear envelope disassembly (GO:0007077) | 2.68085239 |
| 183 | ncRNA catabolic process (GO:0034661) | 2.67315460 |
| 184 | chromatin assembly (GO:0031497) | 2.66258359 |
| 185 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.66230991 |
| 186 | amino acid activation (GO:0043038) | 2.64459700 |
| 187 | tRNA aminoacylation (GO:0043039) | 2.64459700 |
| 188 | telomere maintenance via telomerase (GO:0007004) | 2.63575966 |
| 189 | DNA ligation (GO:0006266) | 2.63550388 |
| 190 | spindle assembly checkpoint (GO:0071173) | 2.63269854 |
| 191 | peptidyl-arginine N-methylation (GO:0035246) | 2.60992281 |
| 192 | peptidyl-arginine methylation (GO:0018216) | 2.60992281 |
| 193 | DNA double-strand break processing (GO:0000729) | 2.60958480 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.74153285 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.78239005 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.07029222 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.32557332 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.88486735 |
| 6 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.52779219 |
| 7 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 3.41258023 |
| 8 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 3.31363338 |
| 9 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.27864603 |
| 10 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.18600896 |
| 11 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.16548598 |
| 12 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.06018100 |
| 13 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.84841149 |
| 14 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.74919664 |
| 15 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.57423738 |
| 16 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.54652210 |
| 17 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.42424642 |
| 18 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.35821370 |
| 19 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.35806830 |
| 20 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.34699653 |
| 21 | * MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.28739586 |
| 22 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.25891996 |
| 23 | * E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.17165906 |
| 24 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.12162606 |
| 25 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 2.10955021 |
| 26 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.03011094 |
| 27 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.97458167 |
| 28 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.96843949 |
| 29 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.96747307 |
| 30 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.93801788 |
| 31 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.93191007 |
| 32 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.93111730 |
| 33 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.91844799 |
| 34 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.89419308 |
| 35 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.88936071 |
| 36 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.86822386 |
| 37 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.86690900 |
| 38 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.83845031 |
| 39 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.78383344 |
| 40 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.77851359 |
| 41 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.75290293 |
| 42 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.75227519 |
| 43 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.75066432 |
| 44 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.70056147 |
| 45 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.68624538 |
| 46 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.63803939 |
| 47 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.61312653 |
| 48 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.57461198 |
| 49 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.57045664 |
| 50 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.57045664 |
| 51 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.57045664 |
| 52 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.53955256 |
| 53 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.52210772 |
| 54 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.51967942 |
| 55 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.51008385 |
| 56 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.47876121 |
| 57 | EWS_26573619_Chip-Seq_HEK293_Human | 1.47847351 |
| 58 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.46901089 |
| 59 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.45981726 |
| 60 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.45380965 |
| 61 | FUS_26573619_Chip-Seq_HEK293_Human | 1.45343815 |
| 62 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.43119324 |
| 63 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.41992362 |
| 64 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.40621257 |
| 65 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.38586791 |
| 66 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.37793367 |
| 67 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.36201410 |
| 68 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.35558521 |
| 69 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.34849016 |
| 70 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.34351130 |
| 71 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.33742144 |
| 72 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.31083528 |
| 73 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.27865347 |
| 74 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.27798951 |
| 75 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.27079459 |
| 76 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.26987251 |
| 77 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.26069498 |
| 78 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.24202224 |
| 79 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.22964169 |
| 80 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.22340394 |
| 81 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.22006831 |
| 82 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.19691318 |
| 83 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.18374894 |
| 84 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.17094574 |
| 85 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.16967159 |
| 86 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.16477984 |
| 87 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.14923391 |
| 88 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.14863162 |
| 89 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.12282767 |
| 90 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.11738947 |
| 91 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.11479375 |
| 92 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.11158725 |
| 93 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.10893720 |
| 94 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 1.10287941 |
| 95 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.09876983 |
| 96 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.09656322 |
| 97 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.09425396 |
| 98 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.08860138 |
| 99 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.08729039 |
| 100 | ATF3_27146783_Chip-Seq_COLON_Human | 1.08108557 |
| 101 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.07936691 |
| 102 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.07658766 |
| 103 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07657087 |
| 104 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.07081254 |
| 105 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.03929236 |
| 106 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 1.03041021 |
| 107 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.02343623 |
| 108 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.01707692 |
| 109 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.01518706 |
| 110 | P300_19829295_ChIP-Seq_ESCs_Human | 1.00241374 |
| 111 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.99691268 |
| 112 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.99297875 |
| 113 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.98670124 |
| 114 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 0.97396568 |
| 115 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.96993792 |
| 116 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.96894955 |
| 117 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.96363815 |
| 118 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.92562721 |
| 119 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.92385179 |
| 120 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.91643309 |
| 121 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.91385478 |
| 122 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.91239959 |
| 123 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.90192483 |
| 124 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.89838649 |
| 125 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.89240274 |
| 126 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.89001339 |
| 127 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.88965144 |
| 128 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.88267774 |
| 129 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.87931142 |
| 130 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.87516347 |
| 131 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.87246133 |
| 132 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 0.86935723 |
| 133 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.86837496 |
| 134 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.86471296 |
| 135 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.84523443 |
| 136 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 0.84227742 |
| 137 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.84130276 |
| 138 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.82588791 |
| 139 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.82408603 |
| 140 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.81537867 |
| 141 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.80857339 |
| 142 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80694296 |
| 143 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.79584002 |
| 144 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.79261462 |
| 145 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.79011909 |
| 146 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.78694579 |
| 147 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.77920927 |
| 148 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.77741863 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.82669975 |
| 2 | MP0005360_urolithiasis | 5.72684880 |
| 3 | MP0005365_abnormal_bile_salt | 4.50202001 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.25101924 |
| 5 | MP0003705_abnormal_hypodermis_morpholog | 4.14971665 |
| 6 | MP0000569_abnormal_digit_pigmentation | 3.81737293 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.54959377 |
| 8 | MP0003941_abnormal_skin_development | 3.50352355 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.22109736 |
| 10 | MP0008875_abnormal_xenobiotic_pharmacok | 3.06105611 |
| 11 | MP0008057_abnormal_DNA_replication | 2.92121317 |
| 12 | MP0010352_gastrointestinal_tract_polyps | 2.62873099 |
| 13 | MP0008932_abnormal_embryonic_tissue | 2.45480047 |
| 14 | MP0009840_abnormal_foam_cell | 2.42356723 |
| 15 | MP0008058_abnormal_DNA_repair | 2.41240017 |
| 16 | MP0003252_abnormal_bile_duct | 2.31264349 |
| 17 | MP0001293_anophthalmia | 2.16903929 |
| 18 | MP0008438_abnormal_cutaneous_collagen | 2.16608433 |
| 19 | MP0008877_abnormal_DNA_methylation | 2.10650203 |
| 20 | MP0003937_abnormal_limbs/digits/tail_de | 2.05465017 |
| 21 | MP0002697_abnormal_eye_size | 1.98558036 |
| 22 | MP0006292_abnormal_olfactory_placode | 1.95388215 |
| 23 | MP0005670_abnormal_white_adipose | 1.88375348 |
| 24 | MP0003191_abnormal_cellular_cholesterol | 1.86254176 |
| 25 | MP0004019_abnormal_vitamin_homeostasis | 1.84527796 |
| 26 | MP0005332_abnormal_amino_acid | 1.79638971 |
| 27 | MP0000609_abnormal_liver_physiology | 1.76234066 |
| 28 | MP0005083_abnormal_biliary_tract | 1.76199787 |
| 29 | MP0003186_abnormal_redox_activity | 1.73461603 |
| 30 | MP0003136_yellow_coat_color | 1.65171833 |
| 31 | MP0004130_abnormal_muscle_cell | 1.64136308 |
| 32 | MP0005319_abnormal_enzyme/_coenzyme | 1.61026664 |
| 33 | MP0001188_hyperpigmentation | 1.59651848 |
| 34 | MP0001299_abnormal_eye_distance/ | 1.56140751 |
| 35 | MP0003121_genomic_imprinting | 1.50710052 |
| 36 | MP0002118_abnormal_lipid_homeostasis | 1.50350722 |
| 37 | MP0009053_abnormal_anal_canal | 1.49955644 |
| 38 | MP0005666_abnormal_adipose_tissue | 1.47865986 |
| 39 | MP0004233_abnormal_muscle_weight | 1.47337751 |
| 40 | MP0003693_abnormal_embryo_hatching | 1.46851379 |
| 41 | MP0004957_abnormal_blastocyst_morpholog | 1.44744459 |
| 42 | MP0000604_amyloidosis | 1.43206133 |
| 43 | MP0001529_abnormal_vocalization | 1.42429342 |
| 44 | MP0001666_abnormal_nutrient_absorption | 1.40678600 |
| 45 | MP0003890_abnormal_embryonic-extraembry | 1.38632290 |
| 46 | MP0001286_abnormal_eye_development | 1.38318505 |
| 47 | MP0005076_abnormal_cell_differentiation | 1.36858835 |
| 48 | MP0010234_abnormal_vibrissa_follicle | 1.32449844 |
| 49 | MP0000579_abnormal_nail_morphology | 1.30612548 |
| 50 | MP0003861_abnormal_nervous_system | 1.30187199 |
| 51 | MP0010307_abnormal_tumor_latency | 1.29047234 |
| 52 | MP0003718_maternal_effect | 1.28312765 |
| 53 | MP0010030_abnormal_orbit_morphology | 1.25931305 |
| 54 | MP0002938_white_spotting | 1.25740594 |
| 55 | MP0004185_abnormal_adipocyte_glucose | 1.24756344 |
| 56 | MP0003111_abnormal_nucleus_morphology | 1.22287796 |
| 57 | MP0001730_embryonic_growth_arrest | 1.21281581 |
| 58 | MP0003221_abnormal_cardiomyocyte_apopto | 1.20835964 |
| 59 | MP0000537_abnormal_urethra_morphology | 1.20334657 |
| 60 | MP0003077_abnormal_cell_cycle | 1.19172095 |
| 61 | MP0000778_abnormal_nervous_system | 1.18797833 |
| 62 | MP0002233_abnormal_nose_morphology | 1.18592345 |
| 63 | MP0002111_abnormal_tail_morphology | 1.18170134 |
| 64 | MP0006035_abnormal_mitochondrial_morpho | 1.17865904 |
| 65 | MP0001915_intracranial_hemorrhage | 1.15644949 |
| 66 | MP0000598_abnormal_liver_morphology | 1.14864159 |
| 67 | MP0010094_abnormal_chromosome_stability | 1.13923141 |
| 68 | MP0000428_abnormal_craniofacial_morphol | 1.13807929 |
| 69 | MP0000049_abnormal_middle_ear | 1.10920494 |
| 70 | MP0004858_abnormal_nervous_system | 1.10795715 |
| 71 | MP0003566_abnormal_cell_adhesion | 1.10490980 |
| 72 | MP0003122_maternal_imprinting | 1.10206315 |
| 73 | MP0004270_analgesia | 1.05199158 |
| 74 | MP0004197_abnormal_fetal_growth/weight/ | 1.02770941 |
| 75 | MP0003567_abnormal_fetal_cardiomyocyte | 1.01824502 |
| 76 | MP0009697_abnormal_copulation | 1.00259307 |
| 77 | MP0002254_reproductive_system_inflammat | 0.97590716 |
| 78 | MP0005380_embryogenesis_phenotype | 0.97253577 |
| 79 | MP0001672_abnormal_embryogenesis/_devel | 0.97253577 |
| 80 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.97065396 |
| 81 | MP0002086_abnormal_extraembryonic_tissu | 0.93734387 |
| 82 | MP0009672_abnormal_birth_weight | 0.93634355 |
| 83 | MP0002751_abnormal_autonomic_nervous | 0.93491049 |
| 84 | MP0000358_abnormal_cell_content/ | 0.93249859 |
| 85 | MP0000647_abnormal_sebaceous_gland | 0.93176983 |
| 86 | MP0009115_abnormal_fat_cell | 0.93017603 |
| 87 | MP0000432_abnormal_head_morphology | 0.92611161 |
| 88 | MP0000350_abnormal_cell_proliferation | 0.92256350 |
| 89 | MP0003755_abnormal_palate_morphology | 0.92101813 |
| 90 | MP0006072_abnormal_retinal_apoptosis | 0.90812794 |
| 91 | MP0002088_abnormal_embryonic_growth/wei | 0.88364199 |
| 92 | MP0005395_other_phenotype | 0.87837452 |
| 93 | MP0002970_abnormal_white_adipose | 0.87585842 |
| 94 | MP0002736_abnormal_nociception_after | 0.86133797 |
| 95 | MP0003984_embryonic_growth_retardation | 0.86059300 |
| 96 | MP0002090_abnormal_vision | 0.85956166 |
| 97 | MP0002081_perinatal_lethality | 0.85535006 |
| 98 | MP0005187_abnormal_penis_morphology | 0.85214163 |
| 99 | MP0005266_abnormal_metabolism | 0.85013233 |
| 100 | MP0004272_abnormal_basement_membrane | 0.84923871 |
| 101 | MP0003935_abnormal_craniofacial_develop | 0.84224888 |
| 102 | MP0002184_abnormal_innervation | 0.83037993 |
| 103 | MP0003385_abnormal_body_wall | 0.82817962 |
| 104 | MP0003329_amyloid_beta_deposits | 0.82024463 |
| 105 | MP0004133_heterotaxia | 0.81067722 |
| 106 | MP0001881_abnormal_mammary_gland | 0.80890964 |
| 107 | MP0003868_abnormal_feces_composition | 0.80612782 |
| 108 | MP0001984_abnormal_olfaction | 0.79050778 |
| 109 | MP0003119_abnormal_digestive_system | 0.78624677 |
| 110 | MP0003942_abnormal_urinary_system | 0.78201509 |
| 111 | MP0005023_abnormal_wound_healing | 0.78195310 |
| 112 | MP0003787_abnormal_imprinting | 0.77851438 |
| 113 | MP0002152_abnormal_brain_morphology | 0.77445673 |
| 114 | MP0003011_delayed_dark_adaptation | 0.76855081 |
| 115 | MP0000955_abnormal_spinal_cord | 0.76823474 |
| 116 | MP0003656_abnormal_erythrocyte_physiolo | 0.75000914 |
| 117 | MP0005334_abnormal_fat_pad | 0.73768033 |
| 118 | MP0001177_atelectasis | 0.73449086 |
| 119 | MP0003115_abnormal_respiratory_system | 0.72891969 |
| 120 | MP0002102_abnormal_ear_morphology | 0.72873338 |
| 121 | MP0005275_abnormal_skin_tensile | 0.72635335 |
| 122 | MP0005257_abnormal_intraocular_pressure | 0.72612325 |
| 123 | MP0005391_vision/eye_phenotype | 0.72602663 |
| 124 | MP0005499_abnormal_olfactory_system | 0.71539239 |
| 125 | MP0005394_taste/olfaction_phenotype | 0.71539239 |
| 126 | MP0002080_prenatal_lethality | 0.71392019 |
| 127 | MP0003091_abnormal_cell_migration | 0.70881269 |
| 128 | MP0009643_abnormal_urine_homeostasis | 0.70617240 |
| 129 | MP0002210_abnormal_sex_determination | 0.70610561 |
| 130 | MP0002084_abnormal_developmental_patter | 0.70538765 |
| 131 | MP0002971_abnormal_brown_adipose | 0.69920543 |
| 132 | MP0004811_abnormal_neuron_physiology | 0.69871019 |
| 133 | MP0002877_abnormal_melanocyte_morpholog | 0.69158572 |
| 134 | MP0003938_abnormal_ear_development | 0.68727461 |
| 135 | MP0008770_decreased_survivor_rate | 0.68506327 |
| 136 | MP0000313_abnormal_cell_death | 0.68254468 |
| 137 | MP0009763_increased_sensitivity_to | 0.67804047 |
| 138 | MP0003315_abnormal_perineum_morphology | 0.65990781 |
| 139 | MP0002295_abnormal_pulmonary_circulatio | 0.65683750 |
| 140 | MP0001697_abnormal_embryo_size | 0.64581959 |
| 141 | MP0005647_abnormal_sex_gland | 0.64527679 |
| 142 | MP0001764_abnormal_homeostasis | 0.64394904 |
| 143 | MP0005375_adipose_tissue_phenotype | 0.64172605 |
| 144 | MP0005376_homeostasis/metabolism_phenot | 0.62777363 |
| 145 | MP0008789_abnormal_olfactory_epithelium | 0.61240320 |
| 146 | MP0000631_abnormal_neuroendocrine_gland | 0.60899753 |
| 147 | MP0005448_abnormal_energy_balance | 0.60767985 |
| 148 | MP0002138_abnormal_hepatobiliary_system | 0.60634594 |
| 149 | MP0001145_abnormal_male_reproductive | 0.59589148 |
| 150 | MP0001661_extended_life_span | 0.59324894 |
| 151 | MP0000762_abnormal_tongue_morphology | 0.59241833 |
| 152 | MP0009703_decreased_birth_body | 0.58429083 |
| 153 | MP0003123_paternal_imprinting | 0.57621274 |
| 154 | MP0000490_abnormal_crypts_of | 0.57527753 |
| 155 | MP0002092_abnormal_eye_morphology | 0.57509088 |
| 156 | MP0005166_decreased_susceptibility_to | 0.56950254 |
| 157 | MP0004883_abnormal_blood_vessel | 0.55927707 |
| 158 | MP0000371_diluted_coat_color | 0.55555896 |
| 159 | MP0002085_abnormal_embryonic_tissue | 0.54248841 |
| 160 | MP0008007_abnormal_cellular_replicative | 0.53247181 |
| 161 | MP0003448_altered_tumor_morphology | 0.51624683 |
| 162 | MP0003075_altered_response_to | 0.50799937 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 4.91658430 |
| 2 | Xanthomatosis (HP:0000991) | 4.41140424 |
| 3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.31467265 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 4.31295590 |
| 5 | Intrahepatic cholestasis (HP:0001406) | 4.06196208 |
| 6 | Hypoalphalipoproteinemia (HP:0003233) | 3.93306854 |
| 7 | Hypolipoproteinemia (HP:0010981) | 3.92037289 |
| 8 | Hyperammonemia (HP:0001987) | 3.75467794 |
| 9 | Epidermoid cyst (HP:0200040) | 3.72801929 |
| 10 | Hyperglycinuria (HP:0003108) | 3.68945209 |
| 11 | Cortical dysplasia (HP:0002539) | 3.66267310 |
| 12 | Spastic diplegia (HP:0001264) | 3.61641771 |
| 13 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.49299313 |
| 14 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.44449064 |
| 15 | Hyperlipoproteinemia (HP:0010980) | 3.44174210 |
| 16 | Abnormality of glycine metabolism (HP:0010895) | 3.40504490 |
| 17 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.40504490 |
| 18 | Complement deficiency (HP:0004431) | 3.33319943 |
| 19 | Hyperglycinemia (HP:0002154) | 3.32307311 |
| 20 | Myocardial infarction (HP:0001658) | 3.24410205 |
| 21 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.24301094 |
| 22 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.19678712 |
| 23 | Chromsome breakage (HP:0040012) | 3.15967572 |
| 24 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.05028897 |
| 25 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.04896357 |
| 26 | Upper motor neuron abnormality (HP:0002127) | 3.00850985 |
| 27 | Multiple enchondromatosis (HP:0005701) | 2.95672104 |
| 28 | Septo-optic dysplasia (HP:0100842) | 2.94223033 |
| 29 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.93723102 |
| 30 | Prolonged partial thromboplastin time (HP:0003645) | 2.92918331 |
| 31 | Birth length less than 3rd percentile (HP:0003561) | 2.87466186 |
| 32 | Hepatoblastoma (HP:0002884) | 2.84840901 |
| 33 | Ketosis (HP:0001946) | 2.82056182 |
| 34 | Abnormal cartilage morphology (HP:0002763) | 2.79860550 |
| 35 | Back pain (HP:0003418) | 2.79664752 |
| 36 | Embryonal renal neoplasm (HP:0011794) | 2.78823676 |
| 37 | Abnormality of the lower motor neuron (HP:0002366) | 2.78344699 |
| 38 | Skin nodule (HP:0200036) | 2.76530456 |
| 39 | Abnormality of complement system (HP:0005339) | 2.74897643 |
| 40 | Meckel diverticulum (HP:0002245) | 2.67400322 |
| 41 | Hypercholesterolemia (HP:0003124) | 2.64024499 |
| 42 | Amyotrophic lateral sclerosis (HP:0007354) | 2.56497039 |
| 43 | Increased nuchal translucency (HP:0010880) | 2.52671512 |
| 44 | Abnormality of the motor neurons (HP:0002450) | 2.51092057 |
| 45 | Abnormal neuron morphology (HP:0012757) | 2.51092057 |
| 46 | Abnormality of the ileum (HP:0001549) | 2.50007154 |
| 47 | Abnormal lung lobation (HP:0002101) | 2.48788174 |
| 48 | Abnormality of serum amino acid levels (HP:0003112) | 2.47963597 |
| 49 | Shoulder girdle muscle weakness (HP:0003547) | 2.45850357 |
| 50 | Abnormality of the common coagulation pathway (HP:0010990) | 2.42147422 |
| 51 | Abnormality of methionine metabolism (HP:0010901) | 2.41989431 |
| 52 | Colon cancer (HP:0003003) | 2.40874253 |
| 53 | Bilateral microphthalmos (HP:0007633) | 2.40556951 |
| 54 | Rhabdomyosarcoma (HP:0002859) | 2.40506937 |
| 55 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.40459307 |
| 56 | Hepatocellular carcinoma (HP:0001402) | 2.40314237 |
| 57 | Abnormality of nucleobase metabolism (HP:0010932) | 2.40202260 |
| 58 | Abnormality of chromosome stability (HP:0003220) | 2.39248198 |
| 59 | Medulloblastoma (HP:0002885) | 2.38076389 |
| 60 | Choanal stenosis (HP:0000452) | 2.33515007 |
| 61 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.29053932 |
| 62 | Homocystinuria (HP:0002156) | 2.27299721 |
| 63 | Abnormality of homocysteine metabolism (HP:0010919) | 2.27299721 |
| 64 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.25764787 |
| 65 | Disinhibition (HP:0000734) | 2.24258747 |
| 66 | Abnormality of the astrocytes (HP:0100707) | 2.22847929 |
| 67 | Astrocytoma (HP:0009592) | 2.22847929 |
| 68 | Pseudobulbar signs (HP:0002200) | 2.22239014 |
| 69 | Protrusio acetabuli (HP:0003179) | 2.20482876 |
| 70 | Hypoglycemic coma (HP:0001325) | 2.19429374 |
| 71 | Abnormality of the intrinsic pathway (HP:0010989) | 2.14452568 |
| 72 | Hydroxyprolinuria (HP:0003080) | 2.11777396 |
| 73 | Abnormality of proline metabolism (HP:0010907) | 2.11777396 |
| 74 | Ketoacidosis (HP:0001993) | 2.09746353 |
| 75 | Delayed CNS myelination (HP:0002188) | 2.09137427 |
| 76 | Abnormal number of incisors (HP:0011064) | 2.08968110 |
| 77 | Exercise-induced muscle cramps (HP:0003710) | 2.08055667 |
| 78 | Hypochromic microcytic anemia (HP:0004840) | 2.07661518 |
| 79 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.07639464 |
| 80 | Biliary tract neoplasm (HP:0100574) | 2.05592209 |
| 81 | Increased mean platelet volume (HP:0011877) | 2.05168514 |
| 82 | Abnormality of the septum pellucidum (HP:0007375) | 2.04738650 |
| 83 | Joint hemorrhage (HP:0005261) | 2.04355857 |
| 84 | Cutaneous melanoma (HP:0012056) | 2.03479537 |
| 85 | Bifid tongue (HP:0010297) | 2.03215317 |
| 86 | Partial agenesis of the corpus callosum (HP:0001338) | 2.03133713 |
| 87 | Peritonitis (HP:0002586) | 2.02632684 |
| 88 | Increased serum pyruvate (HP:0003542) | 2.01308629 |
| 89 | Abnormality of glycolysis (HP:0004366) | 2.01308629 |
| 90 | Gastrointestinal carcinoma (HP:0002672) | 1.99978615 |
| 91 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.99978615 |
| 92 | Volvulus (HP:0002580) | 1.98307672 |
| 93 | Facial cleft (HP:0002006) | 1.97177631 |
| 94 | Ependymoma (HP:0002888) | 1.97172038 |
| 95 | Lymphangioma (HP:0100764) | 1.96899500 |
| 96 | Hand muscle atrophy (HP:0009130) | 1.96659130 |
| 97 | Esophageal varix (HP:0002040) | 1.96010505 |
| 98 | Abnormality of the carotid arteries (HP:0005344) | 1.95888911 |
| 99 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.95875281 |
| 100 | Absent septum pellucidum (HP:0001331) | 1.95344199 |
| 101 | Pelvic girdle muscle weakness (HP:0003749) | 1.95340194 |
| 102 | Subacute progressive viral hepatitis (HP:0006572) | 1.95145827 |
| 103 | Ankle contracture (HP:0006466) | 1.95037787 |
| 104 | Fat malabsorption (HP:0002630) | 1.94465735 |
| 105 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.94128001 |
| 106 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.94128001 |
| 107 | Absent radius (HP:0003974) | 1.93150736 |
| 108 | Abnormality of the Achilles tendon (HP:0005109) | 1.92444073 |
| 109 | Shallow orbits (HP:0000586) | 1.91206705 |
| 110 | Facial hemangioma (HP:0000329) | 1.89047266 |
| 111 | Sensorimotor neuropathy (HP:0007141) | 1.88964915 |
| 112 | Glioma (HP:0009733) | 1.88669967 |
| 113 | Absent eyebrow (HP:0002223) | 1.88666524 |
| 114 | Skull defect (HP:0001362) | 1.88203421 |
| 115 | Abnormality of purine metabolism (HP:0004352) | 1.88078859 |
| 116 | Overriding aorta (HP:0002623) | 1.87945129 |
| 117 | Spontaneous abortion (HP:0005268) | 1.85463245 |
| 118 | Abnormality of the preputium (HP:0100587) | 1.85171150 |
| 119 | Breast aplasia (HP:0100783) | 1.84758713 |
| 120 | Absent forearm bone (HP:0003953) | 1.84619404 |
| 121 | Aplasia involving forearm bones (HP:0009822) | 1.84619404 |
| 122 | Wrist flexion contracture (HP:0001239) | 1.83552305 |
| 123 | Insidious onset (HP:0003587) | 1.83090683 |
| 124 | Termporal pattern (HP:0011008) | 1.83090683 |
| 125 | Neoplasm of the colon (HP:0100273) | 1.82705575 |
| 126 | Protruding tongue (HP:0010808) | 1.82418633 |
| 127 | Myelomeningocele (HP:0002475) | 1.81894704 |
| 128 | Pendular nystagmus (HP:0012043) | 1.79690777 |
| 129 | Aplasia/Hypoplasia of the breasts (HP:0010311) | 1.77660464 |
| 130 | Neonatal onset (HP:0003623) | 1.77286586 |
| 131 | Esophageal atresia (HP:0002032) | 1.76507896 |
| 132 | Stenosis of the external auditory canal (HP:0000402) | 1.76480609 |
| 133 | Uterine neoplasm (HP:0010784) | 1.75512217 |
| 134 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.75249209 |
| 135 | Angiofibromas (HP:0010615) | 1.74727108 |
| 136 | Adenoma sebaceum (HP:0009720) | 1.74727108 |
| 137 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.73954749 |
| 138 | Selective tooth agenesis (HP:0001592) | 1.69077691 |
| 139 | Optic nerve hypoplasia (HP:0000609) | 1.68425397 |
| 140 | Cutaneous syndactyly (HP:0012725) | 1.68239051 |
| 141 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.68211071 |
| 142 | Hypertriglyceridemia (HP:0002155) | 1.67841087 |
| 143 | Horseshoe kidney (HP:0000085) | 1.67206325 |
| 144 | Duodenal stenosis (HP:0100867) | 1.66575903 |
| 145 | Small intestinal stenosis (HP:0012848) | 1.66575903 |
| 146 | Neoplasm of the small intestine (HP:0100833) | 1.66216348 |
| 147 | Elfin facies (HP:0004428) | 1.65860540 |
| 148 | Turricephaly (HP:0000262) | 1.65728620 |
| 149 | Breast carcinoma (HP:0003002) | 1.65003227 |
| 150 | Global brain atrophy (HP:0002283) | 1.64485587 |
| 151 | Abnormality of the duodenum (HP:0002246) | 1.64372594 |
| 152 | Drooling (HP:0002307) | 1.64338624 |
| 153 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.63923962 |
| 154 | Neoplasm of the liver (HP:0002896) | 1.63665777 |
| 155 | Neoplasm of the adrenal cortex (HP:0100641) | 1.63621697 |
| 156 | Nausea (HP:0002018) | 1.63212130 |
| 157 | Urinary urgency (HP:0000012) | 1.63150611 |
| 158 | Anophthalmia (HP:0000528) | 1.61945109 |
| 159 | Status epilepticus (HP:0002133) | 1.61912340 |
| 160 | Apathy (HP:0000741) | 1.61892036 |
| 161 | Abnormality of the labia minora (HP:0012880) | 1.61829548 |
| 162 | Lethargy (HP:0001254) | 1.61351919 |
| 163 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.61136845 |
| 164 | Abnormality of alanine metabolism (HP:0010916) | 1.61136845 |
| 165 | Hyperalaninemia (HP:0003348) | 1.61136845 |
| 166 | High anterior hairline (HP:0009890) | 1.60874750 |
| 167 | Aqueductal stenosis (HP:0002410) | 1.60752134 |
| 168 | Dandy-Walker malformation (HP:0001305) | 1.60694845 |
| 169 | Spinal muscular atrophy (HP:0007269) | 1.60317305 |
| 170 | Embryonal neoplasm (HP:0002898) | 1.60162477 |
| 171 | Thrombophlebitis (HP:0004418) | 1.60042399 |
| 172 | Diminished motivation (HP:0000745) | 1.59387979 |
| 173 | Hypoplasia of the pons (HP:0012110) | 1.58455170 |
| 174 | Cutaneous finger syndactyly (HP:0010554) | 1.58286175 |
| 175 | Generalized hypotonia (HP:0001290) | 1.57964423 |
| 176 | Maternal diabetes (HP:0009800) | 1.57894792 |
| 177 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.56742767 |
| 178 | Progressive muscle weakness (HP:0003323) | 1.56363606 |
| 179 | Conjunctival telangiectasia (HP:0000524) | 1.55810313 |
| 180 | Abnormal platelet volume (HP:0011876) | 1.54996729 |
| 181 | Rimmed vacuoles (HP:0003805) | 1.53880635 |
| 182 | Opisthotonus (HP:0002179) | 1.52446593 |
| 183 | Agnosia (HP:0010524) | 1.51871495 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MARK1 | 4.35381872 |
| 2 | PKN2 | 3.91088609 |
| 3 | TSSK6 | 3.43459488 |
| 4 | TRIB3 | 2.85238899 |
| 5 | SRPK1 | 2.84770003 |
| 6 | TAF1 | 2.70365117 |
| 7 | TNIK | 2.67464264 |
| 8 | SCYL2 | 2.56704352 |
| 9 | PBK | 2.54569101 |
| 10 | RIPK1 | 2.43123306 |
| 11 | MKNK1 | 2.41423804 |
| 12 | MKNK2 | 2.39636271 |
| 13 | LATS2 | 2.37424834 |
| 14 | SIK1 | 2.22804758 |
| 15 | NEK1 | 2.22055220 |
| 16 | MST1R | 2.17226769 |
| 17 | CDC7 | 2.13654098 |
| 18 | ZAK | 2.09110243 |
| 19 | BCKDK | 2.01301691 |
| 20 | DYRK2 | 1.99471837 |
| 21 | EIF2AK1 | 1.80301585 |
| 22 | ACVR1B | 1.73271588 |
| 23 | BCR | 1.72929385 |
| 24 | MAP3K10 | 1.68204284 |
| 25 | WEE1 | 1.67398821 |
| 26 | VRK2 | 1.65716779 |
| 27 | CASK | 1.65710142 |
| 28 | EEF2K | 1.58468740 |
| 29 | ERBB4 | 1.56304914 |
| 30 | PDK3 | 1.56299095 |
| 31 | PDK4 | 1.56299095 |
| 32 | ERBB3 | 1.50934138 |
| 33 | LATS1 | 1.48982951 |
| 34 | PNCK | 1.48632773 |
| 35 | PLK4 | 1.48026749 |
| 36 | STK38L | 1.43269098 |
| 37 | DYRK3 | 1.41550658 |
| 38 | WNK3 | 1.40779799 |
| 39 | CAMK1G | 1.33931898 |
| 40 | TESK2 | 1.31969200 |
| 41 | KSR1 | 1.31487526 |
| 42 | TTK | 1.28442692 |
| 43 | TRIM28 | 1.27314461 |
| 44 | DAPK2 | 1.21671089 |
| 45 | BUB1 | 1.21405958 |
| 46 | CDK6 | 1.21185555 |
| 47 | CDK19 | 1.19859046 |
| 48 | ABL2 | 1.18205332 |
| 49 | SIK2 | 1.16679372 |
| 50 | RPS6KA4 | 1.15191167 |
| 51 | FRK | 1.15151064 |
| 52 | CSNK1G1 | 1.11301458 |
| 53 | PDGFRA | 1.10728572 |
| 54 | BRSK2 | 1.09009315 |
| 55 | CAMK1D | 1.08725456 |
| 56 | NTRK2 | 1.07790739 |
| 57 | DAPK1 | 1.03076090 |
| 58 | TTN | 1.03003040 |
| 59 | CSNK1G2 | 1.01124104 |
| 60 | CDK12 | 0.99666375 |
| 61 | ERN1 | 0.99294997 |
| 62 | LMTK2 | 0.96062865 |
| 63 | BRD4 | 0.95849905 |
| 64 | VRK1 | 0.95591806 |
| 65 | ALK | 0.94942547 |
| 66 | EPHA2 | 0.92912137 |
| 67 | ATM | 0.91647404 |
| 68 | NUAK1 | 0.90555181 |
| 69 | DDR2 | 0.90387892 |
| 70 | MAP3K9 | 0.89132408 |
| 71 | MAP3K4 | 0.88727945 |
| 72 | KSR2 | 0.88357137 |
| 73 | TESK1 | 0.86815406 |
| 74 | MTOR | 0.83668199 |
| 75 | CSNK1E | 0.83184743 |
| 76 | PLK1 | 0.82789653 |
| 77 | CSNK1G3 | 0.82637227 |
| 78 | TYRO3 | 0.82618586 |
| 79 | EIF2AK3 | 0.82163656 |
| 80 | MAP2K4 | 0.81705311 |
| 81 | GRK6 | 0.79484379 |
| 82 | MAP3K8 | 0.79476717 |
| 83 | MAP2K1 | 0.79411360 |
| 84 | CSNK1A1L | 0.78992096 |
| 85 | STK10 | 0.78503786 |
| 86 | NME1 | 0.77766666 |
| 87 | PAK4 | 0.76261838 |
| 88 | CDK7 | 0.75754541 |
| 89 | AURKA | 0.74934412 |
| 90 | PLK3 | 0.74761369 |
| 91 | BMPR1B | 0.72539887 |
| 92 | FGFR1 | 0.72201889 |
| 93 | PAK6 | 0.71828076 |
| 94 | MST4 | 0.71566632 |
| 95 | MAP3K6 | 0.71375861 |
| 96 | NTRK1 | 0.71371022 |
| 97 | TAOK2 | 0.71074582 |
| 98 | NEK2 | 0.70912094 |
| 99 | PAK3 | 0.70570262 |
| 100 | PLK2 | 0.70565998 |
| 101 | PIK3CA | 0.70343282 |
| 102 | MAP2K7 | 0.68682494 |
| 103 | CDK1 | 0.67430036 |
| 104 | RPS6KB2 | 0.66933464 |
| 105 | PAK2 | 0.66891806 |
| 106 | EIF2AK2 | 0.66845991 |
| 107 | FLT3 | 0.64035708 |
| 108 | MINK1 | 0.63741042 |
| 109 | EPHB2 | 0.62385207 |
| 110 | STK3 | 0.60794917 |
| 111 | PHKG2 | 0.60409774 |
| 112 | PHKG1 | 0.60409774 |
| 113 | CHEK2 | 0.60289093 |
| 114 | PRKDC | 0.58434875 |
| 115 | MAPK11 | 0.57977785 |
| 116 | MAP3K11 | 0.57738489 |
| 117 | AURKB | 0.57222791 |
| 118 | FGFR4 | 0.56571356 |
| 119 | LRRK2 | 0.55801004 |
| 120 | CDK4 | 0.55770989 |
| 121 | LIMK1 | 0.55140459 |
| 122 | SMG1 | 0.55079975 |
| 123 | CDK18 | 0.53860306 |
| 124 | PRKCI | 0.53402327 |
| 125 | TGFBR1 | 0.53381112 |
| 126 | PTK6 | 0.53117092 |
| 127 | PDK2 | 0.52016285 |
| 128 | MAP3K5 | 0.51287348 |
| 129 | CDK15 | 0.50802022 |
| 130 | RET | 0.50681167 |
| 131 | CDK14 | 0.50561459 |
| 132 | MAPK13 | 0.49451483 |
| 133 | BMX | 0.48771640 |
| 134 | CDK11A | 0.47890686 |
| 135 | ERBB2 | 0.46635294 |
| 136 | PRKCZ | 0.46349694 |
| 137 | MAPK4 | 0.45813011 |
| 138 | CHEK1 | 0.45560349 |
| 139 | ATR | 0.45369114 |
| 140 | CDK2 | 0.44840241 |
| 141 | ILK | 0.44034023 |
| 142 | PTK2 | 0.42867487 |
| 143 | CSNK2A2 | 0.42536122 |
| 144 | EGFR | 0.41525706 |
| 145 | MET | 0.40728032 |
| 146 | AKT2 | 0.40330417 |
| 147 | CDK3 | 0.39855077 |
| 148 | CSNK1D | 0.39197963 |
| 149 | CSNK2A1 | 0.37201156 |
| 150 | PRKCG | 0.36221293 |
| 151 | BRSK1 | 0.33500531 |
| 152 | GSK3B | 0.33358620 |
| 153 | STK24 | 0.32656530 |
| 154 | BRAF | 0.31149790 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.38663349 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.28739273 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.96405647 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.89813463 |
| 5 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.81474298 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.76431754 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.75785316 |
| 8 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.71761903 |
| 9 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.60163794 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.44411914 |
| 11 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.21727470 |
| 12 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.21689565 |
| 13 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.18599911 |
| 14 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.15559113 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.15457759 |
| 16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.13797229 |
| 17 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.10657059 |
| 18 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.06329821 |
| 19 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.06317962 |
| 20 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.94425566 |
| 21 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.94336462 |
| 22 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.93310558 |
| 23 | Basal transcription factors_Homo sapiens_hsa03022 | 1.88537623 |
| 24 | Carbon metabolism_Homo sapiens_hsa01200 | 1.85086118 |
| 25 | Base excision repair_Homo sapiens_hsa03410 | 1.84119378 |
| 26 | RNA polymerase_Homo sapiens_hsa03020 | 1.83353855 |
| 27 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.82694916 |
| 28 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.81331584 |
| 29 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.80506630 |
| 30 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.76624816 |
| 31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.75352341 |
| 32 | Homologous recombination_Homo sapiens_hsa03440 | 1.72212487 |
| 33 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.68122148 |
| 34 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.66337573 |
| 35 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.64077354 |
| 36 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.63606104 |
| 37 | RNA degradation_Homo sapiens_hsa03018 | 1.58714792 |
| 38 | Peroxisome_Homo sapiens_hsa04146 | 1.55367525 |
| 39 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.54543568 |
| 40 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.46977493 |
| 41 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.41303444 |
| 42 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.41231479 |
| 43 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.34125673 |
| 44 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.28847627 |
| 45 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.25780834 |
| 46 | Protein export_Homo sapiens_hsa03060 | 1.21100418 |
| 47 | Sulfur relay system_Homo sapiens_hsa04122 | 1.20553763 |
| 48 | Adherens junction_Homo sapiens_hsa04520 | 1.20304871 |
| 49 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.18098151 |
| 50 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.17578847 |
| 51 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.16078008 |
| 52 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.15591825 |
| 53 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.12874706 |
| 54 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.11470824 |
| 55 | Bile secretion_Homo sapiens_hsa04976 | 1.10613240 |
| 56 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.05990494 |
| 57 | Retinol metabolism_Homo sapiens_hsa00830 | 1.05805481 |
| 58 | Thyroid cancer_Homo sapiens_hsa05216 | 1.05593051 |
| 59 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.05337715 |
| 60 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.02808883 |
| 61 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.99472815 |
| 62 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.99004076 |
| 63 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.97135239 |
| 64 | Tight junction_Homo sapiens_hsa04530 | 0.93905502 |
| 65 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.92176160 |
| 66 | Purine metabolism_Homo sapiens_hsa00230 | 0.92095361 |
| 67 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.89852042 |
| 68 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.87685055 |
| 69 | Lysine degradation_Homo sapiens_hsa00310 | 0.87440091 |
| 70 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.82868494 |
| 71 | Proteasome_Homo sapiens_hsa03050 | 0.80812956 |
| 72 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.79433026 |
| 73 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.79200730 |
| 74 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.78213917 |
| 75 | RNA transport_Homo sapiens_hsa03013 | 0.75366565 |
| 76 | Nicotine addiction_Homo sapiens_hsa05033 | 0.74770834 |
| 77 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.69980911 |
| 78 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.66520198 |
| 79 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.65918553 |
| 80 | Histidine metabolism_Homo sapiens_hsa00340 | 0.64902984 |
| 81 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.64673774 |
| 82 | Galactose metabolism_Homo sapiens_hsa00052 | 0.60817062 |
| 83 | Mismatch repair_Homo sapiens_hsa03430 | 0.59365513 |
| 84 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.58549860 |
| 85 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.58251162 |
| 86 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.57598917 |
| 87 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.56921404 |
| 88 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.56342944 |
| 89 | DNA replication_Homo sapiens_hsa03030 | 0.55590811 |
| 90 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.55536823 |
| 91 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.55073333 |
| 92 | Ribosome_Homo sapiens_hsa03010 | 0.55007419 |
| 93 | Huntingtons disease_Homo sapiens_hsa05016 | 0.49567279 |
| 94 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.48624320 |
| 95 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.46015756 |
| 96 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.45712416 |
| 97 | Axon guidance_Homo sapiens_hsa04360 | 0.45447460 |
| 98 | Parkinsons disease_Homo sapiens_hsa05012 | 0.45414272 |
| 99 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.44523160 |
| 100 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.44038158 |
| 101 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.41471113 |
| 102 | Alcoholism_Homo sapiens_hsa05034 | 0.40356744 |
| 103 | Legionellosis_Homo sapiens_hsa05134 | 0.40269092 |
| 104 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.40148785 |
| 105 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.39855151 |
| 106 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.39567876 |
| 107 | Viral myocarditis_Homo sapiens_hsa05416 | 0.38358835 |
| 108 | Colorectal cancer_Homo sapiens_hsa05210 | 0.37311463 |
| 109 | Melanoma_Homo sapiens_hsa05218 | 0.36254390 |
| 110 | Taste transduction_Homo sapiens_hsa04742 | 0.34180806 |
| 111 | Phototransduction_Homo sapiens_hsa04744 | 0.32901090 |
| 112 | Cell cycle_Homo sapiens_hsa04110 | 0.32540713 |
| 113 | Prion diseases_Homo sapiens_hsa05020 | 0.32398536 |
| 114 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.31526047 |
| 115 | Bladder cancer_Homo sapiens_hsa05219 | 0.30629044 |
| 116 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.30225944 |
| 117 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.29275522 |
| 118 | Metabolic pathways_Homo sapiens_hsa01100 | 0.27474054 |
| 119 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.27123879 |
| 120 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.26625745 |
| 121 | Insulin resistance_Homo sapiens_hsa04931 | 0.26280812 |
| 122 | Spliceosome_Homo sapiens_hsa03040 | 0.24673410 |
| 123 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.22161198 |
| 124 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.21697938 |
| 125 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.21562224 |
| 126 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.21525063 |
| 127 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21425201 |
| 128 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.19931296 |
| 129 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.19878311 |
| 130 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.19691305 |
| 131 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.19601804 |
| 132 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.19058047 |
| 133 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.18284334 |
| 134 | Endometrial cancer_Homo sapiens_hsa05213 | 0.17952074 |
| 135 | Amoebiasis_Homo sapiens_hsa05146 | 0.17412972 |
| 136 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.17371325 |
| 137 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.15282233 |
| 138 | Phagosome_Homo sapiens_hsa04145 | 0.14937524 |
| 139 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.14910095 |
| 140 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.14905757 |

